Aβ Cancer Research Results
Aβ, Aβ aggregation: Click to Expand ⟱
| Source: |
| Type: |
Beta-Amyloid (Aβ): In Alzheimer’s disease, Aβ peptides tend to misfold and aggregate into oligomers and fibrils.
|
Nor, Normal Healthy: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
*eff↑, BBB↑, ChemoSen↑, *Inflam↓, *NO↓, *TNF-α↓, *IL6↓, *Bacteria↓, *eff↑, *Aβ↓, *SOD↑, *neuroP↑, *EPR↑, toxicity↓, P-gp↓, eff↑, other↝,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
*BBB↓, *GutMicro↑, Obesity↓, *Inflam↓, *AntiCan↑, *TRPV1↑, *Ca+2↑, *antiOx↑, *cardioP↑, *BioAv↓, *Half-Life↓, *BioAv↝, *BioAv↑, *neuroP↑, Apoptosis↑, p38↑, ROS↑, MMP↓, MPT↑, Cyt‑c↑, Casp↑, TRIB3↑, NADH↓, SIRT1↓, TumCG↓, TumCMig↓, TOP1↓, TOP2↓, β-catenin/ZEB1↓, *ROS↓, *Aβ↓,
*antiOx↑, *Obesity↓, *memory↑, *Aβ↓, *MAPK↓, *NF-kB↓, *iNOS↓, *COX2↓, *IL1β↓, *TNF-α↓, *NF-kB↓,
*memory↑, *Aβ↓, *tau↓,
*Imm↑, *GastroP↑, *Inflam↓, AntiCan↑, *AntiBio↑, *hepatoP↑, *CD4+↑, *IFN-γ↓, *IL17↓, *GutMicro↑, *antiOx↑, *AST↓, *ALAT↓, *HDL↑, *LDL↓, *ROS↓, *lipid-P↓, *Inflam↓, *Aβ↓,
*antiOx↑, *Inflam↓, *AntiCan↑, *cardioP↑, *neuroP↑, *GutMicro↑, *AntiBio↑, *ROS↓, *TNF-α↓, *IL6↓, TumCP↓, *LDL↓, *NO↓, *Obesity↓, *p‑tau↓, *Aβ↓, *NRF2↑, *SOD↑, *Catalase↑, *GPx↑, *NLRP3↓, *mTOR↓, TumCCA↑, NRF2↓, Apoptosis↑, SIRT1↓, miR-25-5p↓, PARP↑, Casp3↑, Casp9↑, ER Stress↑, TumAuto↑, EMT↓, TumCI↓, TumCMig↓, TGF-β↓, Smad1↓, STAT3↓, VEGF↓, angioG↓, Imm↑, EGFR↓, *GutMicro↑, *Bacteria↓, *AntiViral↑, *BioAv↓, *BioAv↑, *eff↑, *BioAv↑, eff↑, ChemoSen↑, *toxicity↝,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*antiOx↑, *ROS↓, *neuroP↑, *NO↑, BioAv↝, *BBB↑, *toxicity↑, *eff↑, *GSH↑, *SOD↑, *Aβ↓, *12LOX↓, *COX2↓, *Catalase↑, *Inflam↓, *TNF-α↓, *IL6↑, *lipid-P↓, NF-kB↓, IL1β↓, NRF2↑, HO-1↑, GSTs↑, cognitive↑, *BDNF↑,
*antiOx↑, AntiCan↑, *cardioP↑, *XO↓, *COX2↓, *5LO↓, *PI3K↓, *AChE↓, *Imm⇅, *BP↓, TumCCA↑, *Aβ↓, *BACE↓, *NF-kB↓, *ROS↓, *neuroP↑, *AntiAg↑, *AntiThr↑,
| - |
in-vivo, |
AD, |
NA |
|
|
|
- |
in-vitro, |
Nor, |
PC12 |
|
|
|
*cognitive↑, *p‑PI3K↓, *p‑Akt↓, *AMPK↑, *VDAC1↓, *neuroP↑, *PARK2↑, *PTEN↑, *LC3‑Ⅱ/LC3‑Ⅰ↑, *p62↓, *Aβ↓, *Apoptosis↓,
Showing Research Papers: 1 to 9 of 9
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 9
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
GSTs↑, 1, HO-1↑, 1, NADH↓, 1, NRF2↓, 1, NRF2↑, 1, ROS↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
MMP↓, 1, MPT↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
SIRT1↓, 2,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 2, Casp↑, 1, Casp3↑, 1, Casp9↑, 1, Cyt‑c↑, 1, p38↑, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
miR-25-5p↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
other↝, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
ER Stress↑, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
TumAuto↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
PARP↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
TumCCA↑, 2,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
EMT↓, 1, STAT3↓, 1, TOP1↓, 1, TOP2↓, 1, TumCG↓, 1,
Migration(tgid=13) ⓘ
Smad1↓, 1, TGF-β↓, 1, TRIB3↑, 1, TumCI↓, 1, TumCMig↓, 2, TumCP↓, 1, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1, EGFR↓, 1, VEGF↓, 1,
Barriers & Transport(tgid=15) ⓘ
BBB↑, 1, P-gp↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
IL1β↓, 1, Imm↑, 1, NF-kB↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↝, 1, ChemoSen↑, 2, eff↑, 2,
Clinical Biomarkers(tgid=22) ⓘ
EGFR↓, 1, TRIB3↑, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 2, cognitive↑, 1, Obesity↓, 1, toxicity↓, 1,
Total Targets: 50
Pathway results for Effect on Normal Cells:
NA, unassigned(tgid=0) ⓘ
AntiBio↑, 2,
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 6, Catalase↑, 2, GPx↑, 1, GSH↑, 1, HDL↑, 1, lipid-P↓, 2, NRF2↑, 1, PARK2↑, 1, ROS↓, 5, SOD↑, 3, VDAC1↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
12LOX↓, 1, ALAT↓, 1, AMPK↑, 1, LDL↓, 2,
Cell Death(tgid=5) ⓘ
p‑Akt↓, 1, Apoptosis↓, 1, iNOS↓, 1, MAPK↓, 1, TRPV1↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
AntiThr↑, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
LC3‑Ⅱ/LC3‑Ⅰ↑, 1, p62↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
mTOR↓, 1, PI3K↓, 1, p‑PI3K↓, 1, PTEN↑, 1,
Migration(tgid=13) ⓘ
5LO↓, 1, AntiAg↑, 1, Ca+2↑, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
EPR↑, 1, NO↓, 2, NO↑, 1,
Barriers & Transport(tgid=15) ⓘ
BBB↓, 1, BBB↑, 1, GastroP↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
CD4+↑, 1, COX2↓, 3, IFN-γ↓, 1, IL17↓, 1, IL1β↓, 1, IL6↓, 2, IL6↑, 1, Imm↑, 1, Imm⇅, 1, Inflam↓, 6, NF-kB↓, 3, TNF-α↓, 4,
Synaptic & Neurotransmission(tgid=18) ⓘ
AChE↓, 1, BDNF↑, 1, tau↓, 1, p‑tau↓, 1,
Protein Aggregation(tgid=19) ⓘ
Aβ↓, 9, BACE↓, 1, NLRP3↓, 1, XO↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 2, BioAv↑, 3, BioAv↝, 1, eff↑, 4, Half-Life↓, 1,
Clinical Biomarkers(tgid=22) ⓘ
ALAT↓, 1, AST↓, 1, BP↓, 1, GutMicro↑, 4, IL6↓, 2, IL6↑, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 2, cardioP↑, 3, cognitive↑, 1, hepatoP↑, 1, memory↑, 2, neuroP↑, 6, Obesity↓, 2, toxicity↑, 1, toxicity↝, 1,
Infection & Microbiome(tgid=24) ⓘ
AntiViral↑, 1, Bacteria↓, 2,
Total Targets: 79
Scientific Paper Hit Count for: Aβ, Aβ aggregation
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:1333 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page